Status:
COMPLETED
Immediate Post-placental Insertion of IUCD During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion
Lead Sponsor:
ALshaimaa Aboalhassan Ali
Conditions:
Mechanical Complication of Intrauterine Device
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
The aim of current study is to compare the rates of IUCD expulsion and complications in immediate post-placental insertion versus delayed IUCD insertion (6-weeks after cesarean delivery)
Detailed Description
Intrauterine devices (IUDs) are among the most effective forms of contraception, offering greater than 99% efficacy per year of use and are completely reversible . Post-placental intrauterine device ...
Eligibility Criteria
Inclusion
- Age: 18 -45
- Singleton pregnancy at ≥32 weeks gestation at time of enrollment
- Voluntarily requesting to IUD placement for postpartum contraception
- Able to give consent and agree to the terms of the study
Exclusion
- Uterine anomaly that preventing replacement of IUD.
- Chorioamnionitis (such as prolonged rupture of membranes \>18 hours, prolonged labor \>24 hours, fever \>38C).
- Puerperal sepsis and unresolved postpartum hemorrhage.
- IUD allergy (copper).
- Systemic lupus erythematosus with severe thrombocytopenia
Key Trial Info
Start Date :
September 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03404622
Start Date
September 20 2016
End Date
December 20 2017
Last Update
January 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams Maternity Hospital
Cairo, Egypt, 11311